Literature DB >> 15570200

Surgical management of primary hyperparathyroidism: the case for giving up quick intraoperative PTH assay in favor of routine PTH measurement the morning after.

Marta Mozzon1, Pierre-E Mortier, Paul M Jacob, Benoit Soudan, A Arnold Boersma, Charles A-G Proye.   

Abstract

OBJECTIVE: To analyze the utility of quick intraoperative parathyroid hormone (PTH) measurement in the surgical management of primary hyperparathyroidism. BACKGROUND DATA: The use of intraoperative PTH monitoring is well established in the surgery of primary hyperparathyroidism. However, some false-negative predictions lead to unnecessary explorations; furthermore, surgeons are becoming increasingly dependent on hormone measurement for intraoperative decisions, which raises concerns about the cost-effectiveness of the method.
METHODS: A retrospective analysis of 268 neck explorations performed for primary hyperparathyroidism using intraoperative PTH monitoring from April 2001 to February 2003 was done. We used the criterion of "biologic recovery" of hyperfunctioning tissue, defined as a more than 50% decrease in PTH level from baseline value at 5 minutes after excision to predict the outcome of successful parathyroidectomy documented by normal postoperative serum calcium level. Additionally, we also sampled PTH at 10 minutes, 30 minutes, and the morning after surgery to compare the predictive value of delayed sampling. Patients were classified according to the prediction being concordant or discordant with the outcome. The data were analyzed using a 2 x 2 table construct for each of the sampling times, therefore providing sequential sensitivity, specificity, positive and negative predictive values, and overall accuracy of the predictions.
RESULTS: Concordance or overall accuracy of prediction (true positives and negatives) was obtained in 229 cases (85.4%), and discordance or failure of prediction (false positives and negatives) was obtained in 34 cases (12.7%) at T5. On analyzing the iPTH prediction at T10, T30, and D1 among the group of 33 false negatives, we found that 28 (10.4%) patients reached the concordance at 30 minutes, while by the first day 32 patients (12.3%) had achieved concordance. Thus, there was a progressive increase in sensitivity and overall accuracy, but more importantly, in the negative predictive value reaching 88.9% on the day after surgery.
CONCLUSIONS: The method of sampling PTH intraoperatively at 5 minutes has a high positive predictive value (99.5%) but a low negative predictive value (19.5%), which can lead to unnecessary explorations and a delay in the operative procedure. The negative predictive value increases substantially at 30 minutes and is best on the day after surgery. We suggest giving up the intraoperative measurement of PTH to adopt the first day postoperative measurement of PTH as a predictor of successful parathyroidectomy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15570200      PMCID: PMC1356510          DOI: 10.1097/01.sla.0000145927.29265.8a

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  29 in total

1.  Intraoperative parathyroid hormone monitoring fails to detect double parathyroid adenomas: a 2-institution experience.

Authors:  P G Gauger; G Agarwal; B G England; L W Delbridge; K A Matz; M Wilkinson; B G Robinson; N W Thompson
Journal:  Surgery       Date:  2001-12       Impact factor: 3.982

2.  Intraoperative quick parathyroid hormone versus same-day parathyroid hormone testing for minimally invasive parathyroidectomy: a cost-effectiveness study.

Authors:  G Agarwal; M S Barakate; B Robinson; M Wilkinson; B Barraclough; T S Reeve; L W Delbridge
Journal:  Surgery       Date:  2001-12       Impact factor: 3.982

3.  Usefulness and limits of quick intraoperative measurements of intact (1-84) parathyroid hormone in the surgical management of hyperparathyroidism: sequential measurements in patients with multiglandular disease.

Authors:  C A Proye; A Goropoulos; C Franz; B Carnaille; M Vix; J L Quievreux; G Couplet-Lebon; A Racadot
Journal:  Surgery       Date:  1991-12       Impact factor: 3.982

Review 4.  Role of preoperative localization and intraoperative localization maneuvers including intraoperative PTH assay determination for patients with persistent or recurrent hyperparathyroidism.

Authors:  H Richard Alexander; Clara C Chen; Thomas Shawker; Peter Choyke; Teresa J Chan; Richard Chang; Stephen J Marx
Journal:  J Bone Miner Res       Date:  2002-11       Impact factor: 6.741

5.  Targeted parathyroidectomy in the era of intraoperative parathormone monitoring.

Authors:  William B Inabnet; Gregory F Dakin; Richard S Haber; Francesco Rubino; Ed J Diamond; Michel Gagner
Journal:  World J Surg       Date:  2002-05-21       Impact factor: 3.352

6.  Pitfalls of intraoperative quick parathyroid hormone monitoring and gamma probe localization in surgery for primary hyperparathyroidism.

Authors:  Nora T Jaskowiak; Sonia L Sugg; James Helke; Mahalashmana Rao Koka; Edwin L Kaplan
Journal:  Arch Surg       Date:  2002-06

7.  Does intraoperative quick parathyroid hormone assay improve the results of parathyroidectomy?

Authors:  Daishu Miura; Nobuyuki Wada; Cumhur Arici; Eugene Morita; Quan-Yang Duh; Orlo H Clark
Journal:  World J Surg       Date:  2002-04-30       Impact factor: 3.352

8.  Parathyroid hormone: before and after parathyroidectomy.

Authors:  Q Y Duh; C D Arnaud; K E Levin; O H Clark
Journal:  Surgery       Date:  1986-12       Impact factor: 3.982

9.  Minimally invasive video-assisted parathyroidectomy and intraoperative parathyroid hormone monitoring. The first 36 cases and some pitfalls.

Authors:  K K J Hallfeldt; A Trupka; J Gallwas; S Schmidbauer
Journal:  Surg Endosc       Date:  2002-07-29       Impact factor: 4.584

10.  [Intraoperative monitoring of intact parathyroid hormone during surgery for primary hyperparathyroidism].

Authors:  K Hallfeldt; A Trupka; J Gallwas; K Horn
Journal:  Zentralbl Chir       Date:  2002-05       Impact factor: 0.942

View more
  7 in total

1.  The use of intraoperative parathyroid hormone monitoring in minimally invasive parathyroid surgery.

Authors:  J Helbrow; A E Owais; A G Sidwell; L M Frank; M E Lucarotti
Journal:  Ann R Coll Surg Engl       Date:  2016-07-14       Impact factor: 1.891

2.  Validity and limits of intraoperative parathyroid hormone monitoring during minimally invasive parathyroidectomy: a 10-year experience.

Authors:  Alexandra Ozimek; J Gallwas; U Stocker; T Mussack; K K J Hallfeldt; R Ladurner
Journal:  Surg Endosc       Date:  2010-05-20       Impact factor: 4.584

Review 3.  Intraoperative adjuncts in surgery for primary hyperparathyroidism.

Authors:  Barney J Harrison; Frederic Triponez
Journal:  Langenbecks Arch Surg       Date:  2009-07-10       Impact factor: 3.445

4.  Minimally Invasive Parathyroidectomy: Can Intraoperative Parathyroid Hormone Monitoring be Omitted?

Authors:  Shalom Eligal; Michal Mekel; Ron Eliashar; Haggi Mazeh; Jeffrey M Weinberger; Mariya Neymark; Nir Hirshoren; Ido Mizrahi
Journal:  World J Surg       Date:  2022-04-11       Impact factor: 3.282

5.  Intraoperative parathyroid hormone testing in primary hyperparathyroidism surgery: time for giving up?

Authors:  Paola Vincenza Sartori; Alberto Maria Saibene; Ennio Leopaldi; Marco Boniardi; Edoardo Beretta; Samuele Colombo; Emanuela Morenghi; Juliana Pauna; Loredana De Pasquale
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-10-24       Impact factor: 2.503

6.  Impact of modern techniques on short-term outcome after surgery for primary hyperparathyroidism: a multicenter study comprising 2,708 patients.

Authors:  Anders O J Bergenfelz; Svante K G Jansson; Göran K Wallin; Hans G Mårtensson; Lars Rasmussen; Håkan L O Eriksson; Eva I M Reihnér
Journal:  Langenbecks Arch Surg       Date:  2009-07-18       Impact factor: 3.445

7.  Feasibility of video-assisted bilateral neck exploration for patients with primary hyperparathyroidism and failed or discordant localization studies.

Authors:  Pier Francesco Alesina; Jakob Hinrichs; Matthias Heuer; Sebastian Hofmeister; Beate Meier; Martin K Walz
Journal:  Langenbecks Arch Surg       Date:  2012-11-25       Impact factor: 3.445

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.